The global electroencephalography (EEG) devices market size is expected to reach USD 2.92 billion by 2032, according to a new study by Polaris Market Research. The report “Electroencephalography (EEG) Devices Market Share, Size, Trends, Industry Analysis Report, By Modality (Portable, Standalone); By Product; By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Electroencephalography (EEG) devices are medical devices used to measure and record the brain's electrical activity. EEG is a non-invasive technique that involves placing electrodes on the scalp to detect and record the electrical signals generated by the brain's neurons.
The EEG devices consist of electrodes connected to an amplifier or a computer system. These electrodes pick up the electrical signals produced by the brain and convert them into waveforms that healthcare professionals can analyze and interpret.
EEG is commonly used in clinical settings to diagnose and monitor neurological conditions like epilepsy, sleep disorders, brain tumors, and brain injuries. It helps healthcare professionals to evaluate brain function, detect abnormalities, and assess the effectiveness of treatments.
In addition to clinical applications, EEG devices are utilized in research settings to study brain activity, cognitive processes, and the effects of certain stimuli or interventions on the brain.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/electroencephalography-eeg-devices-market/request-for-sample
Several key factors drive the growth of the electroencephalography (EEG) equipment market. The increasing elderly population and the growing adoption of EEG equipment in surgical centers are major contributors—additionally, the rising prevalence of neurological disorders like epilepsy and Alzheimer's disease further fuels market growth.
Technological advancements in EEG equipment also play a significant role in driving market growth. However, the presence of substitute products poses a challenge to market expansion. On the other hand, there is substantial growth potential in developing nations, presenting lucrative opportunities for the global EEG equipment market in the forecast period.
The growth of the electroencephalography (EEG) devices market is driven by the rising prevalence of neurological conditions and growing awareness about them. Neurological disorders such as epilepsy, Alzheimer's, multiple sclerosis, dementia, stroke, and Parkinson's disease have increased demand for EEG devices. For example, In 2022, according to the Association for Alzheimer's Disease, approximately 6.5 million Americans aged 65 and older will be affected by Alzheimer's, with 73% being 75 years or older. This data highlights the significant impact of neurological disorders on adopting EEG devices.
Electroencephalography (EEG) Devices Market Report Highlights
Polaris Market Research has segmented the electroencephalography (EEG) devices market report based on modality, product, application, end-use, and region:
Electroencephalography (EEG) Devices, Modality Outlook (Revenue - USD Billion, 2019 - 2032)
Electroencephalography (EEG) Devices, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Electroencephalography (EEG) Devices, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Electroencephalography (EEG) Devices, End-Use (Revenue - USD Billion, 2019 - 2032)
Electroencephalography (EEG) Devices, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
Report Attributes |
Details |
Market size value in 2023 |
USD 2.16 billion |
Revenue forecast in 2032 |
USD 2.92 billion |
CAGR |
3.4% from 2023 – 2032 |
Base year |
2022 |
Historical data |
2019 – 2021 |
Forecast period |
2023 – 2032 |
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2032 |
Segments Covered |
By Modality, By Product, By Application, By End-Use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Key Companies |
Cephalon A/S, BrainScope Company Inc., Electrical Geodesics, Inc., Compumedics Ltd., Elekta AB, Koninklijke Philips, NeuroScience Inc., Lifelines Neurodiagnostic Devices Inc., Bio-Signal Group Corp., Natus Medical, Inc., Medtronic, Neurosoft Ltd., Cadwell Laboratories, Inc., Nihon Kohden America, Inc., and NeuroWave Devices, Inc. |
For Specific Research Requirements |